Tokyo, April 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061129) titled 'Evaluation of Skin Condition Changes Following Face sheet Mask Use After Cosmetic Medical Procedures' on April 2.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Non-randomized Blinding - Open -no one is blinded Control - Placebo

Primary Sponsor: Institute - Shin-Kawasaki Eve Clinic for Dermatology and Aesthetic Medicine

Condition: Condition - Adult Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To assess the impact of sheet mask application on skin condition post-cosmetic medical procedures Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Participants will apply a facial sheet mask immediately after treatment, followed by seven additional applications over a 28-day period according to a predefined schedule Interventions/Control_2 - Apply Petrolatum immediately after the treatment, followed for seven additional applications over a 28-day period according to a predefined schedule

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1) Individuals aged 18 or older at the time of obtaining consent. 2) Individuals who wish to undergo laser treatment. 3) Individuals who have received a full explanation of the purpose and content of the research, have the capacity to give consent, fully understand the information, voluntarily volunteer to participate, and provide written consent to participate in the research. Key exclusion criteria - 1) Individuals whom the principal investigator has determined to have differences in skin condition between the left and right sides of their face. 2) Individuals who plan to undergo cosmetic medical procedures on their face other than those covered by this study during the study period. 3) Individuals at risk of developing an allergic reaction to cosmetics or to ingredients contained in the test products used in this study. 4) Individuals who are pregnant or breastfeeding at the time of consent, or who wish to become pregnant during the study period. 5) Individuals who have participated in another human study within the past four weeks, or who plan to participate in another human study during the period of participation in this study. 6)Any other individuals deemed unsuitable for participation in the study by the principal investigator. Target Size - 10

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 03 Month 26 Day Date of IRB - 2026 Year 03 Month 26 Day Anticipated trial start date - 2026 Year 04 Month 03 Day Last follow-up date - 2026 Year 10 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069937

Disclaimer: Curated by HT Syndication.